Zynex has been granted FDA clearance for its NexWave electrotherapy device, according to a Zynex news release. NexWave delivers three modalities of stimulation: interferential, neuromuscular ... The stock continued to rally for a bit, but the shares have now drifted down below where they were at the last time we looked at Zynex.
In addition, the company recently got a new FDA approval. Seeking Alpha: Zynex Is A Quality Company, But You Must Pay For Quality Products sold in the past by Zynex for pain management have failed to penetrate the market. Zynex's new products are radically different from their predecessors: more specific and innovative. The new ...
zynex nexwave, Zynex missed on second-quarter revenue and earnings, and guided down. However, some of the near-term weakness was by design, as the company is cutting costs. The stock looks very cheap if the company ... Zynex (NASDAQ:ZYXI) will release its quarterly earnings report on Tuesday, 2025-04-29. Here's a brief overview for investors ahead of the announcement.
zynex nexwave, Analysts anticipate Zynex to report an earnings ... Zynex (NASDAQ:ZYXI) is gearing up to announce its quarterly earnings on Thursday, 2024-10-24. Here's a quick overview of what investors should know before the release. Analysts are estimating that ... ENGLEWOOD, Colo., Feb. 4, 2026 /PRNewswire/ -- Zynex, Inc.
(ZYXIQ), an innovative medical device company specializing in non-invasive medical devices for pain management, announced it has for the ...
